Transcriptional Regulation of EGR1 by EGF and the ERK Signaling Pathway in Prostate Cancer Cells

Genes and Cancer

Volumn 2, Issue 9, 2011, Pages 900-909

  Gregg, Jennifer ^a,b   Fraizer, Gail ^a  

^a KENT STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

EGF; EGR1; Elk 1; prostate cancer

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR ELK 1;

ARTICLE; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EARLY GROWTH RESPONSE GENE 1; EARLY RESPONSE GENE; GENE DELETION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM RESPONSIVE ELEMENT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 84868645464     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911431885     Document Type: Article

References (58)

1. Yan SF,Fujita T,Lu J, et al.Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress.Nat Med. 2000;6:1355-61.
2. Thiel G,Cibelli G.Regulation of life and death by the zinc finger transcription factor egr-1.J Cell Physiol. 2002;193:287-92.
3. Tumor Biol. Adamson EDMercola D, ed. 2002:93-102.
4. Levin WJ,Press MF,Gaynor RB, et al.Expression patterns of immediate early transcription factors in human non-small cell lung cancer.Oncogene. 1995;11:1261-9.
5. Joslin JM,Fernald AA,Tennant TR, et al.Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders.Blood. 2007;110:719-26.
6. Huang RP,Fan Y,De Belle I, et al.Decreased egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation.Int J Cancer. 1997;72:102-9.
7. Calogero A,Arcella A,De Gregorio G, et al.The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.Clin Cancer Res. 2001 2788;7:.
8. Nat Cell Biol. Virolle TAdamson EDBaron V, ed. 2001:1124-8.
9. Krones-Herzig A,Mittal S,Yule K, et al.Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53.Cancer Res. 2005;65:5133-43.
10. Levkovitz Y,Baraban JM.A dominant negative egr inhibitor blocks nerve growth factor-induced neurite outgrowth by suppressing c-jun activation: role of an Egr/c-jun complex.J Neurosci. 2002;22:3845-3854.
11. Thigpen AE,Cala KM,Guileyardo JM,Molberg KH,McConnell JD,Russell DW.Increased expression of early growth response-1 messenger ribonucleic acid in prostatic adenocarcinoma.J Urol. 1996;155:975-81.
12. Eid MA.Expression of early growth response genes in human prostate cancer.Cancer Res. 1998;58:2461-8.
13. Mol Cell Biol. Svaren JSevetson BRApel EDZimonjic DBPopescu NCMilbrandt J, ed. 1996:3545-53.
14. Baron V,De Gregorio G,Krones-Herzig A, et al.Inhibition of egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo.Oncogene. 2003;22:4194-204.
15. Morgan M,Saba S,Gower W.Fibronectin influences cellular proliferation and apoptosis similarly in LNCaP and PC-3 prostate cancer cell lines.Urol Oncol. 2000;5:155-9.
16. Muraoka-Cook RS,Kurokawa H,Koh Y, et al.Conditional overexpression of active transforming growth factor β1 in vivo accelerates metastases of transgenic mammary tumors.Cancer Res. 2004;64:9002.
17. Hodge C,Liao J,Stofega M,Guan K,Carter-Su C,Schwartz J.Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2.J Biol Chem. 1998;273:31327.
18. Hoffmann E,Ashouri J,Wolter S, et al.Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-jun pathway.J Biol Chem. 2008;283:12120-8.
19. Kaufmann K,Thiel G.Epidermal growth factor and thrombin induced proliferation of immortalized human keratinocytes is coupled to the synthesis of egr-1, a zinc finger transcriptional regulator.J Cell Biochem. 2002;85:381-91.
20. Tsai JC,Liu L,Zhang J,Spokes KC,Topper JN,Aird WC.Epidermal growth factor induces egr-1 promoter activity in hepatocytes in vitro and in vivo.Am J Physiol Gastrointest Liver Physiol. 2001;281:1271-8.
21. Soulitzis N,Karyotis I,Delakas D,Spandidos DA.Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.Int J Oncol. 2006;29:305-14.
22. Scher HI,Sarkis A,Reuter V, et al.Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms.Clin Cancer Res. 1995;1:545-50.
23. Ching KZ,Ramsey E,Pettigrew N,D'cunha R,Jason M,Dodd JG.Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines.Mol Cell Biochem. 1993;126:151-8.
24. Di Lorenzo G,Tortora G,D'Armiento FP, et al.Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.Clin Cancer Res. 2002;8:3438-44.
25. J Pathol. Bartlett JMSBrawley DGrigor KMunro AFDunne BEdwards J, ed. 2005:522-9.
26. Gille H,Kortenjann M,Thomae O, et al.ERK phosphorylation potentiates elk-1-mediated ternary complex formation and transactivation.EMBO J. 1995;14:951-62.
27. Janknecht R,Ernst W,Pingoud V,Nordheim A.Activation of ternary complex factor elk-1 by MAP kinases.EMBO J. 1993;12:5097.
28. Sharrocks A.Complexities in ETS-domain transcription factor function and regulation: Lessons from the TCF (ternary complex factor) subfamily.Biochem Soc Trans. 2002;30:1-9.
29. Whitmarsh AJ,Yang SH,Su MS,Sharrocks AD,Davis RJ.Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors.Mol Cell Biol. 1997;17:2360-71.
30. Cruzalegui FH,Cano E,Treisman R.ERK activation induces phosphorylation of elk-1 at multiple S/T-P motifs to high stoichiometry.Oncogene. 1999;18:7948-57.
31. Yang SH,Whitmarsh AJ,Davis RJ,Sharrocks AD.Differential targeting of MAP kinases to the ETS-domain transcription factor elk-1.EMBO J. 1998;17:1740-9.
32. Gille H,Sharrocks AD,Shaw PE.Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter.Nature. 1992;358:414-417.
33. Hill CS,Marais R,John S,Wynne J,Dalton S,Treisman R.Functional analysis of a growth factor-responsive transcription factor complex.Cell. 1993;73:395-406.
34. Qureshi SA,Cao XM,Sukhatme VP,Foster DA.v-src activates mitogen-responsive transcription factor egr-1 via serum response elements.J Biol Chem. 1991;266:10802-6.
35. Mora-Garcia P,Sakamoto KM.Granulocyte colony-stimulating factor induces egr-1 up-regulation through interaction of serum response element-binding proteins.J Biol Chem. 2000;275:22418-26.
36. Gann PH,Klein KG,Chatterton RT, et al.Growth factors in expressed prostatic fluid from men with prostate cancer, BPH, and clinically normal prostates.Prostate. 1999;40:248-55.
37. Abdulkadir SA,Qu Z,Garabedian E, et al.Impaired prostate tumorigenesis in Egr1-deficient mice.Nat Med. 2001;7:101-7.
38. Svaren J,Ehrig T,Abdulkadir SA,Ehrengruber MU,Watson MA,Milbrandt J.EGR1 target genes in prostate carcinoma cells identified by microarray analysis.J Biol Chem. 2000;275:38524-31.
39. Sherwood ER,Van Dongen JL,Wood CG,Liao S,Kozlowski JM,Lee C.Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells.Br J Cancer. 1998;77:855-61.
40. MacDonald A,Habib FK.Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines.Br J Cancer. 1992;65:177-182.
41. Vlietstra RJ,van Alewijk DCJG,Hermans KGL,van Steenbrugge GJ,Trapman J.Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.Cancer Res. 1998;58:2720-2723.
42. Baek SJ,Wilson LC,Hsi LC,Eling TE.Troglitazone, a peroxisome proliferator-activated receptor g (PPARg) ligand, selectively induces early growth response-1 (EGR-1) gene independently of PPARg: A novel mechanism for its anti-tumorigenic activity.J Biol Chem. 2002;278:5845-5853.
43. Chen CC,Lee WR,Safe S.Egr-1 is activated by 17beta-estradiol in MCF-7 cells by mitogen-activated protein kinase-dependent phosphorylation of ELK-1.J Cell Biochem. 2004;93:1063-74.
44. Cohen DM,Gullans SR,Chin WW.Urea inducibility of egr-1 in murine inner medullary collecting duct cells is mediated by the serum response element and adjacent ets motifs.J Biol Chem. 1996;271:12903-8.
45. Aicher WK,Sakamoto KM,Hack A,Eibel H.Analysis of functional elements in the human egr-1 gene promoter.Rheumatol Int. 1999;18:207-14.
46. Shin SY,Lee JH,Min BW,Lee YH.The translation inhibitor anisomycin induces elk-1-mediated transcriptional activation of egr-1 through multiple mitogen-activated protein kinase pathways.Exp Mol Med. 2006;38:677-85.
47. Guha M,O'Connell MA,Pawlinski R, et al.Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor-alpha expression by inducing elk-1 phosphorylation and egr-1 expression.Blood. 2001;98:1429-39.
48. Gineitis D,Treisman R.Differential usage of signal transduction pathways defines two types of serum response factor target gene.J Biol Chem. 2001;276:24531-9.
49. Zhang HM,Li L,Papadopoulou N, et al.Mitogen-induced recruitment of ERK and MSK to SRE promoter complexes by ternary complex factor elk-1.Nucleic Acids Res. 2008;36:2594-607.
50. Vickers ER,Kasza A,Kurnaz IA, et al.Ternary complex factor-serum response factor complex-regulated gene activity is required for cellular proliferation and inhibition of apoptotic cell death.Mol Cell Biol. 2004;24:10340.
51. Vickers ER,Sharrocks AD.The use of inducible engrailed fusion proteins to study the cellular functions of eukaryotic transcription factors.Methods. 2002;26:270-80.
52. Costello P,Nicolas R,Willoughby J,Wasylyk B,Nordheim A,Treisman R.Ternary complex factors SAP-1 and elk-1, but not net, are functionally equivalent in thymocyte development.J Immunol. 2010;185:1082-92.
53. Hernes E,Fossa S,Berner A,Otnes B,Nesland J.Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence.Br J Cancer. 2004;90:449-54.
54. Yang S,Abdulkadir SA.Early growth response gene 1 modulates androgen receptor signaling in prostate carcinoma cells.J Biol Chem. 2003;278:39906-11.
55. Mora GR,Olivier KR,Cheville JC,Mitchell RF,Lingle WL,Tindall DJ.The cytoskeleton differentially localizes the early growth response gene-1 protein in cancer and benign cells of the prostate.Mol Cancer Res. 2004;2:115-28.
56. Yang SZ,Eltoum IA,Abdulkadir SA.Enhanced EGR1 activity promotes the growth of prostate cancer cells in an androgen-depleted environment.J Cell Biochem. 2006;97:1292-9.
57. Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method.Methods. 2001;25:402-408.
58. Hung CC,Liu X,Kwon MY,Kang YH,Chung SW,Perrella MA.Regulation of heme oxygenase-1 gene by peptidoglycan involves the interaction of elk-1 and C/EBP-alpha to increase expression.Am J Physiol Lung Cell Mol Physiol. 2010;298:870-9.